The mTORC1 inhibitors rapamycin and its analogs are recognized to show

The mTORC1 inhibitors rapamycin and its analogs are recognized to show only moderate antitumor activity in clinic however the underlying mechanisms remain mainly elusive. ?(Figure1B).1B). Because of this cap-dependent translation was inhibited Rabbit Polyclonal to SGCA. markedly by mix of rapamycin and MK2206 weighed against either agent only in every the four examined cancers cell… Continue reading The mTORC1 inhibitors rapamycin and its analogs are recognized to show